Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines

(2022) Queenie Fernandes et al.   ANNALS OF MEDICINE

Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies

(2022) Xun Wang et al.   Emerging Microbes & Infections

A third high dose of inactivated COVID-19 vaccine induces higher neutralizing antibodies in humans against the Delta and Omicron variants: a Randomized, Double-Blinded Clinical Trial

(2022) Yu Cao et al.   Science China-Life Sciences

What Omicron’s BA.4 and BA.5 variants mean for the pandemic

(2022) Ewen Callaway   NATURE

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

(2022) Yunlong Cao et al.   NATURE

Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission

(2022) Lok Bahadur Shrestha et al.   REVIEWS IN MEDICAL VIROLOGY

Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5

(2022) Benjamin Hewins et al.   Journal of Infection in Developing Countries

Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection

(2022) Samuel SM Cheng et al.   JOURNAL OF CLINICAL VIROLOGY

Relative vaccine effectiveness of the booster dose of COVID-19 vaccine for preventing death in individuals with a primary regimen based on the BBIBP-CorV, ChAdOx1-S, or BNT162b2 vaccines during the Omicron wave in Peru: A nested case-control study using national population data

(2022) Javier Silva-Valencia et al.   VACCINE

Age and Sex Differences Among Mildly Symptomatic and Asymptomatic Patients with Omicron Infection in 2022 in Shanghai, China

(2022) Can Feng et al.   Journal of Multidisciplinary Healthcare

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

(2021) Xianwen Ren et al.   CELL

Cycle threshold values in RT‐PCR to determine dynamics of SARS‐CoV‐2 viral load: An approach to reduce the isolation period for COVID‐19 patients

(2021) Clara Aranha et al.   JOURNAL OF MEDICAL VIROLOGY

Viral Dynamics and Real-Time RT-PCR Ct Values Correlation with Disease Severity in COVID-19

(2021) Ali A. Rabaan et al.   Diagnostics

Elderly Male With Cardiovascular-Related Comorbidities Has a Higher Rate of Fatal Outcomes: A Retrospective Study in 602 Patients With Coronavirus Disease 2019

(2021) Xiao-Yong Zhan et al.   Frontiers in Cardiovascular Medicine

A Unification of Mediator, Confounder, and Collider Effects

(2021) David P. MacKinnon et al.   PREVENTION SCIENCE

Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients

(2021) Lu Lu et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

(2021) Gang Zeng et al.   LANCET INFECTIOUS DISEASES

To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value

(2020) Michael R Tom et al.   CLINICAL INFECTIOUS DISEASES

Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards

(2020) Bernard La Scola et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage

(2020) Kristijan Skok et al.   VIRCHOWS ARCHIV